Plasma adenosine deaminase isoform 2 in cancer patients undergoing chemotherapy

British Journal of Biomedical Science

Volumn 69, Issue 1, 2012, Pages 11-13

  Roberts, Elton L ^a   Roberts, O T ^a  

^a Bronglais General Hospital   (United Kingdom)

Author keywords

Adenosine deaminase; Drug therapy; Neoplasms; Plasma

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; INOSINE; IRINOTECAN; MITOMYCIN; PREDNISOLONE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHEMICAL STRUCTURE; CLINICAL ARTICLE; COLON CANCER; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; HYDROLYSIS; LYMPHOMA; PLASMA; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH CANCER; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR REGRESSION;

EID: 84860824662     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2012.11669915     Document Type: Article

References (16)

1. Fox IH, Kelley WN. The role of adenosine deaminase and 2′-deoxyadenosine in mammalian cells. Annu Rev Biochem 1978; 47: 655-86.
2. Kaplan AM, Gerrard TL, Strawson J, Squire C, Aultman M. Role of adenosine deaminase in human monocyte differentiation and tumor cell cytotoxicity. Ann NY Acad Sci 1985; 451: 246-78.
3. Gakis C, Calia MC, Naitana GM, Ortu AR, Contu A. Plasma and plural adenosine deaminase activity. Correct interpretation of the findings. Chest 1991; 99 (6): 1555.
4. Fernandez E, Rodrigo L, Riestra S, Garcia S, Gutierrez F, Ocio G. Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol 2000; 30 (2):181-6. (Pubitemid 30148447)
5. Wilkinson JH. In: Diagnostic enzymology. London: Edward Arnold, 1976: 166-8.
6. Ho AD, Ganeshagura K. Enzymes of purine metabolism in lymphoid neoplasms, clinical relevance for treatment with enzyme inhibitors. Klin Wochenschr 1988; 66 (11): 467-74.
7. Walia M, Mahajan M, Singh K. Plasma adenosine deaminase, 5′-nucleotidase & alkaline phosphatase in breast cancer patients. Indian J Med Res 1995; 101: 247-9.
8. Zavialov AV, Gracia E, Glaichenraus N, Franco R, Zavalov AV, Laurau G. Human adenosine deaminase 2 induces differentiation of monocytes and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 2010 88 (2): 279-90.
9. Durak I, Cetin R, Canabolat O, Cetin D, Yurtarlani Z, Unal A. Adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer. Cancer Lett 1994; 84 (2):199-202.
10. Canbolat O, Durak I, Cetin R, Kavutcu M, Demirici S, Ozturk, S. Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat 1996; 37 (2):189-93.
11. Akyol O, Gokbulut I, Koksai N, Akoin H, Ozyurt H, Yildirim Z. The activities of purine catabolizing enzymes in plasma and bronchial washing fluid in patients with lung cancer and pneumonia. Clin Biochem 2001; 34 (3): 251-4. (Pubitemid 32537678)
12. Sanfilippo O, Camici M, Tozzi MG et al. Relationship between the levels of purine salvage pathway enzymes and clinical/ biological aggressiveness of human colon carcinoma. Cancer Biochem Biophys 1994; 14 (1): 57-66. (Pubitemid 2084559)
13. Bukulmez G, Akan T, Ciliv G. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study. Eur J Dermatol 2000; 10 (4): 274-6. (Pubitemid 30319020)
14. Chan ESL, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002; 4 (4): 266-73. (Pubitemid 34716307)
15. Sweetman S. In: Martindale: the complete drug reference 33rd edn. London: Pharmaceutical Press, 2002: 476-581.
16. Roberts EL. Blood levels of selected purine salvage enzymes in the diagnosis and monitoring of cancer patients. PhD Thesis, Swansea, 2006.